F
$ Value
$5.3M
Shares
21,366
Price
$247
Filed
Mar 26
Insider
Name
Anagnost Andrew
Title
President and CEO
CIK
0001661768
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-24
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
147,665
Footnotes
Shares withheld to cover taxes. | The total securities beneficially owned includes 32,582 shares of unvested Restricted Stock Units. | Represents shares earned based upon attainment for Performance Stock Unit awards. 43,091 shares subject to one PSU vested on attainment on 03/24/2026.
Filing Info
Anagnost Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | ADSK | A | $0 |
| 2026-03-24 | ADSK | F | $5.2M |
| 2026-03-24 | ADSK | A | $0 |
| 2026-03-24 | ADSK | F | $5.3M |
| 2025-12-02 | ADSK | G | $0 |
| 2025-06-04 | HUBS | A | $0 |
Other Insiders at ADSK (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Blum Steven M
EVP, Chief Operating Officer
|
— | — | 2026-04-10 |
|
Anagnost Andrew
President and CEO
|
— | — | 2026-04-10 |
|
Moorjani Janesh
EVP, Chief Financial Officer
|
— | — | 2026-04-10 |
|
Keene Ruth Ann
EVP, Corp Affairs, CLO
|
— | — | 2026-04-10 |
|
Pearce Rebecca
EVP, Chief People Officer
|
— | — | 2026-04-10 |